<DOC>
	<DOC>NCT01893489</DOC>
	<brief_summary>Until now, no specific atherosclerosis-targeting agent labeled with positron emitter is not yet available. Investigators developed neomannosyl human serum albumin(MSA) for the terminal mannose residues of MSA binding with the mannose receptors of macrophages in atherosclerosis, and investigators investigate whether 68Ga-MSA can be a novel agent for non-invasive molecular imaging of carotid atherosclerotic lesion in PET.</brief_summary>
	<brief_title>Visualization of Carotid Atherosclerosis by 68Ga-MSA</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<criteria>•coronary artery disease patients with carotid plaques control without carotid plaque •pregnancy, allergy to albumin, any acute or chronic inflammatory disease, hematologic disease, liver disease, renal disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>positron emission tomography</keyword>
	<keyword>macrophage</keyword>
	<keyword>neomannosyl human serum albumin</keyword>
</DOC>